Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

By B. Cole, J. Baron, R. S. Sandier, R. Haile, D. Ahnen, R. Bresalier, G. McKeown-Eyssen, R. Summers, R. Rothstein, C. Burke and 18 more. Journal of the American Medical Association (JAMA), 2007

980 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/0e47e8ac61b006552bf3cd655d3fb86eb4f0356a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. R. Siegel
2. A. Jemal
3. C. DeSantis
4. K. Miller
5. F. Bray
6. J. Ferlay

Citations in the corpus

• Is folic acid good for everyone? (2008, background): “The results from the first randomized trial of folic acid for the prevention of colorectal cancer in genetically predisposed patients (32) showed that treatment with folic acid (1 mg/d) for up to 6 y did not prevent the recurrence of colorectal adenomas.”
• Colorectal cancer statistics, 2014 (2014, positive): “This hypothesis is based on findings that folic acid, the form of folate used in supplements and fortification, promotes carcinogenesis.(45,46) However, a recent analysis of data from the American Cancer Society Cancer Prevention Study II Nutrition Cohort found no evidence that fortification or supp”